Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and prevention
Authors:
Open Access
- 28 May 2024
- journal article
- review article
- Published by Taylor & Francis in Human Fertility
- Vol. 27 (1) , 2352387
Abstract
The association between Medically Assisted Reproduction (MAR) and thromboembolic complications has been reported widely in multiple published studies. Although venous thromboembolism (VTE) is not thought to be a common complication of MAR, it is associated with high morbidity and is often preventable. Since VTE usually occurs after completion of MAR treatment and is often managed outside of the treating fertility unit, these complications are likely to be underreported and there may be limited awareness of the risks among clinicians. As we continue to see a rise in the total number of MAR treatment cycles, particularly in women over 40 years of age, along with a steady increase in the number of fertility preservation cycles for both medical and social indications, it is likely that we will see an increase in absolute numbers of VTE complications. Currently, there is a lack of management guidance and reporting of VTE events associated with assisted conception treatment. The aim of this guidance is to provide clinicians with information on VTE risk factors, guidance on assessing VTE risk and the best practice recommendations on risk reducing strategies for individuals at risk of VTE undergoing ovarian stimulation and embryo transfer cycles.Keywords
This publication has 81 references indexed in Scilit:
- Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivorsBreast Cancer Research and Treatment, 2019
- Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta‐analysis of RCTsAmerican Journal of Hematology, 2016
- Luteal phase support for assisted reproduction cyclesCochrane Database of Systematic Reviews, 2015
- Hypercoagulability in adolescent girls on oral contraceptives‐global coagulation profile and estrogen receptor polymorphismsAmerican Journal of Hematology, 2015
- Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technologyCochrane Database of Systematic Reviews, 2014
- Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservationJournal of Assisted Reproduction and Genetics, 2013
- Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United StatesCancer, 2012
- Androgen deprivation and thromboembolic events in men with prostate cancerCancer, 2011
- Esterified Estrogens and Conjugated Equine Estrogens and the Risk of Venous ThrombosisJAMA, 2004
- Relative Impact of Risk Factors for Deep Vein Thrombosis and Pulmonary EmbolismArchives of internal medicine (1960), 2002